AGM
ORKA

Alpine Global Management’s Oruka Therapeutics ORKA Stock Holding History

Alpine Global Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,393
Closed -$49K – 823
2021
Q3 		$49K Buy
+1,393
New +$51.5K 0.01% 270

Other funds holding ORKA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alpine Global Management's ORKA Position: Q4 2021 in Review

Alpine Global Management sold out of Oruka Therapeutics (ORKA) in Q4 2021, closing a stake of 1,393 shares — an estimated $49K sold.

Alpine Global Management first reported a position in ORKA in Q3 2021 and held it in 1 quarter. The position peaked at $49K in Q3 2021. 20 funds tracked by Wall St. Rank hold ORKA as of Q4 2021.

  • Alpine Global Management reported no remaining Oruka Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Alpine Global Management sold 1,393 Oruka Therapeutics shares in Q4 2021, an estimated $49K.
  • Alpine Global Management first reported a position in Oruka Therapeutics in Q3 2021 and held it in 1 quarter.
  • Alpine Global Management's Oruka Therapeutics position peaked at $49K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2021.

Based on Alpine Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.